Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shulman Joseph, holds the title of Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC..
On 2026-11-18, the insider transacted 86,388 shares.The shares were transacted at a weighted average price of $85.58 per share, resulting in a total market-relevant value of $7.4M.
Shulman Joseph (Chief Technical Officer) sold $7.4M of $RYTM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.